Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Regeneron pharmaceuticals, inc. crawled time : 00:00 save search
Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 0.39%
H: 2.1%
C: 1.48%
Regeneron to Showcase Progress from Innovative Oncology Portfolio in Several Difficult-to-Treat Cancers at ESMO
Published: 2023-10-15 (Crawled : 00:00) - globenewswire.com
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 0.38%
H: 0.5%
C: 0.1%
EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
Published: 2023-02-08 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 4.4%
H: 0.0%
C: 0.0%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: 1.24%
H: 0.0%
C: 0.0%
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 0.22%
H: 0.83%
C: -0.87%
eylea treatment fda approved injection
Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: -0.74%
H: 2.09%
C: 0.48%
KNSA | $18.44 4.3% 56K
|
Health Technology
|
| O: 0.26%
H: 1.53%
C: -2.81%
pharmaceuticals report financial results
ESMO Presentations of Libtayo® (cemiplimab), Fianlimab and Novel Bispecific Antibodies Showcase Expanding Potential of Regeneron's Oncology Pipeline in Multiple Cancers
Published: 2022-09-04 (Crawled : 00:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.1 -1.24% 260K
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $914.08 0.75% 54K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
libtayo potential
Regeneron to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on August 3, 2022
Published: 2022-07-06 (Crawled : 00:00) - biospace.com/
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: -0.3%
H: 1.19%
C: 0.02%
conference report results
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-05-12 (Crawled : 00:00) - biospace.com/
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: -0.97%
H: 0.0%
C: 0.0%
ACET | News | $1.955 -6.91% 520K
|
Health Technology
|
| O: -1.74%
H: 0.0%
C: 0.0%
results
Regeneron to Report First Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2022
Published: 2022-04-05 (Crawled : 00:00) - biospace.com/
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: -0.2%
H: 1.92%
C: -0.8%
conference report results
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-22 (Crawled : 00:00) - globenewswire.com
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: -0.3%
H: 0.92%
C: -1.7%
KNSA | $18.44 4.3% 56K
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: -2.21%
als financial results report results
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-24 (Crawled : 00:00) - fda.gov
PFE | News 4 | $26.21 -0.42% 5M
|
Health Technology
|
| O: 0.33%
H: 0.15%
C: -0.67%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 0.01%
BMY | $48.795 -0.4% 1.5M
|
Health Technology
|
| O: 0.33%
H: 1.03%
C: 0.03%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.4%
H: 0.19%
C: -0.58%
XERS | $1.74 -2.25% 150K
|
Health Technology
|
| O: -1.15%
H: 1.46%
C: -4.66%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.82%
OTIC | $0.077
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -7.2%
OMER | $3.09 38K
|
Health Technology
|
| O: 0.94%
H: 1.4%
C: 1.06%
GILD | $66.85 -0.27% 1M
|
Health Technology
|
| O: 0.51%
H: 0.2%
C: -2.42%
BCRX | News | $4.35 -0.69% 460K
|
Health Technology
|
| O: 0.43%
H: 1.44%
C: -2.16%
AMGN | News | $273.905 0.13% 270K
|
Health Technology
|
| O: -0.18%
H: 1.17%
C: -1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-04-12 (Crawled : 00:00) - fda.gov
PFE | News 4 | $26.21 -0.42% 5M
|
Health Technology
|
| O: -0.33%
H: 1.52%
C: 1.34%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: -0.57%
H: 0.28%
C: -0.88%
BMY | $48.795 -0.4% 1.5M
|
Health Technology
|
| O: -0.13%
H: 0.39%
C: 0.26%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.26%
H: 0.7%
C: 0.4%
XERS | $1.74 -2.25% 150K
|
Health Technology
|
| O: -0.47%
H: 0.12%
C: -6.65%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -0.33%
H: 0.12%
C: -0.69%
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -1.86%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 0.9%
C: -0.45%
OMER | $3.09 38K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.13%
GILD | $66.85 -0.27% 1M
|
Health Technology
|
| O: -0.08%
H: 0.08%
C: -0.61%
BCRX | News | $4.35 -0.69% 460K
|
Health Technology
|
| O: -0.59%
H: 0.1%
C: -6.4%
AMGN | News | $273.905 0.13% 270K
|
Health Technology
|
| O: -0.17%
H: 0.6%
C: 0.17%
NIH-sponsored Trial Finds EYLEA® (aflibercept) Injection Reduced Vision-threatening Complications by 68% after Two Years in Diabetic Retinopathy Patients
Published: 2021-03-30 (Crawled : 00:00) - prnewswire.com
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: 0.59%
H: 0.36%
C: 0.12%
REGN | News | $914.08 0.75% 54K
|
Health Technology
|
| O: 0.42%
H: 0.65%
C: 0.11%
injection trial diabetic diabetes
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.